Millipore Sigma Vibrant Logo

178461 Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein

Native Apolipoprotein C-III from human plasma found in VLDL and chylomicrons. Involved in triglyceride uptake by cells. Inhibits lipoprotein lipase and uptake of lipoprotein remnants by the liver.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Apo C-III

View Products on Sigmaaldrich.com
178461
가격 및 재고 조회

개요

Replacement Information

가격 및 재고여부

카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
178461-100UGCN
재고 정보 검색...
—
현재 재고 없음 현재 재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service

      		 Plastic ampoule 100 μg
      가격 검색...
      가격을 검색할 수 없습니다
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      가격 문의 추가 정보
      ()이 할인됨
       
      —
      가격 문의
      		 —
      Description
      OverviewNative apolipoprotein C-III from human plasma. Major protein of VLDL and chylomicrons. Involved in the uptake of triglycerides by cells. May inhibit the activation of lipoprotein lipase by Apo C-II. Present in normal plasma at 80-150 µg/ml.
      Catalogue Number178461
      Brand Family Calbiochem®
      SynonymsApo C-III
      References
      ReferencesBonnet, E., et al. 2001. J. Clin. Endocrinol. Metab. 86, 296.
      Hasse, R., et al. 1998. Electrophoresis 9, 569.
      Catapano, A.L., et al. 1978. J. Lipid Res. 19, 1047.
      Product Information
      FormLiquid
      FormulationIn 10 mM NH₄HCO₃, pH 7.4.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage -20°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      카탈로그 번호 GTIN
      178461-100UGCN 04055977222524

      Documentation

      Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein MSDS

      타이틀

      물질안전보건자료(MSDS) 

      Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein Certificates of Analysis

      TitleLot Number
      178461

      References

      참고문헌 보기
      Bonnet, E., et al. 2001. J. Clin. Endocrinol. Metab. 86, 296.
      Hasse, R., et al. 1998. Electrophoresis 9, 569.
      Catapano, A.L., et al. 1978. J. Lipid Res. 19, 1047.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-April-2008 RFH
      SynonymsApo C-III
      DescriptionNative apolipoprotein C-III from human plasma. Present in normal plasma at 80-150 µg/ml. Major protein of VLDL and chylomicrons. Involved in the uptake of triglycerides by cells. May inhibit the activation of lipoprotein lipase by Apo C-II.
      FormLiquid
      FormulationIn 10 mM NH₄HCO₃, pH 7.4.
      Concentration Label Please refer to vial label for lot-specific concentration
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Purity≥95% by SDS-PAGE
      Storage Avoid freeze/thaw
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Toxicity Standard Handling
      ReferencesBonnet, E., et al. 2001. J. Clin. Endocrinol. Metab. 86, 296.
      Hasse, R., et al. 1998. Electrophoresis 9, 569.
      Catapano, A.L., et al. 1978. J. Lipid Res. 19, 1047.